<<<<Purpose of Job>>>>>>>
Interns will gain hands-on experience with biopharmaceutical industry projects and studies under the guidance of a mentor, using actual data to address real problems in a stimulating, collaborative and supportive environment. Ability to learn the treatment landscapes of oncology drug development in China and outside of China and gain insight of efficacy and safety of available therapies.
Project area includes organizing and summarizing global clinical trials, studies, presentations, and reports across different data sources in oncology therapeutic area; cross-check and quality-check on data input and information capturing of team members.
Interns are expected to participate in the internship for 20 hours per week at least.
• Supports and works closely with Director in Applied Innovations for data collection and management
• Performs data input, organizing, cleaning/reconciliation activities across different data sources and databases
• Generates and delivers reports to team members
• Ability to present data and findings to team members
• Communicate on data issues.
• Communicate and work with offshore and remote team to address deliverables.
• Undergraduate students entering sophomore year or above from a research university/college or institute, in Data Science, Computer Science, Life Sciences, Medical or other relevant subject
• GPA at least 3.0
• Good English in reading and writing
• Excellent organization skills, detail-oriented to ensure accuracy and reliability of data and information captured
• Excellent oral and written communication skills, interpersonal and teamwork skills
• Problem-solving skills
• Self-management skills
• Proficiency with MS Office
• Medical knowledge in oncology preferred
百济神州是一家全球性的、商业阶段的、以研发为基础的生物科技公司，专注于分子靶向和免疫肿瘤疗法的研发。百济神州目前在中国大陆、美国、澳大利亚和欧洲拥有3500 多名员工，在研产品线包括新型口服小分子类和单克隆抗体类抗癌药物。百济神州目前也正在打造抗癌治疗的药物组合方案，旨在为癌症患者的生活带来持续、深远的影响。百济神州在美国销售其自主研发的BTK 抑制剂BRUKINSA™（泽布替尼）；在中国，其抗PD1 抗体药物百泽安®（替雷利珠单抗）已经获得上市批准。同时，百济与新基公司（属于百时美施贵宝公司）、安进公司具有深入合作，被授权负责多个药品的临床发展或在华销售。欲了解更多信息，请访问ww***.cn[点击查看]。